Evidence map›Paper›PMID 36972319›Full record

ArticlePLoS genetics2023

Identification of gene networks mediating regional resistance to tauopathy in late-onset Alzheimer's disease.

Christopher A Ayoub, Connor S Wagner, Jeff Kuret

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. DnaJs are enriched in tau regulators.International journal of biological macromolecules · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Christopher A AyoubBiomedical Sciences Graduate Program, Ohio State University, Columbus, Ohio, United States of America.
Connor S WagnerDepartment of Biological Chemistry & Pharmacology, Ohio State University, Columbus, Ohio, United States of America.
Jeff KuretDepartment of Biological Chemistry & Pharmacology, Ohio State University, Columbus, Ohio, United States of America.ORCID 0000-0002-8083-8406
The Ohio State University · US

Funding

Structure and Genesis of tau AggregatesRF1AG054018 · NIA · OHIO STATE UNIVERSITY · PI KURET, JEFF · 2017 to 2022
$4.4M
Structure and Genesis of tau AggregatesR01AG054018 · NIA · OHIO STATE UNIVERSITY · PI Jeff Kuret · 2025 to 2026
$1.2M
Decoding Selective Vulnerability: Effectors and Regulators of Tau Lesion Spread in Alzheimer's DiseaseF30AG072804 · NIA · OHIO STATE UNIVERSITY · PI AYOUB, CHRISTOPHER ANTHONY · 2022 to 2024
$134k
NIA NIH HHS F30 AG072804NIA NIH HHS R01 AG054018NIA NIH HHS RF1 AG054018
6 · The paper itself

Abstract

Neurofibrillary lesions composed of tau protein aggregates are defining hallmarks of Alzheimer's Disease. Despite tau filaments appearing to spread between networked brain regions in a prion-like manner, certain areas including cerebellum resist trans-synaptic spread of tauopathy and degeneration of their constituent neuronal cell bodies. To identify molecular correlates of resistance, we derived and implemented a ratio of ratios approach for disaggregating gene expression data on the basis of regional vulnerability to tauopathic neurodegeneration. When applied to vulnerable pre-frontal cortex as an internal reference for resistant cerebellum, the approach segregated adaptive changes in expression into two components. The first was enriched for neuron-derived transcripts associated with proteostasis including specific members of the molecular chaperone family and was unique to resistant cerebellum. When produced as purified proteins, each of the identified chaperones depressed aggregation of 2N4R tau in vitro at sub-stoichiometric concentrations, consistent with the expression polarity deduced from ratio of ratios testing. In contrast, the second component enriched for glia- and microglia-derived transcripts associated with neuroinflammation, segregating these pathways from susceptibility to tauopathy. These data support the utility of ratio of ratios testing for establishing the polarity of gene expression changes with respect to selective vulnerability. The approach has the potential to identify new targets for drug discovery predicated on their ability to promote resistance to disease in vulnerable neuron populations.

Indexed as

Alzheimer DiseaseTauopathiesAge of OnsetGene Regulatory NetworksGenetic LociHumansMolecular ChaperonesTranscription, GeneticMolecular Chaperones

Identifiers

PMID36972319
PMCPMC10079065
OpenAlexW4361017316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.